B N Rathi Securities Regulatory Approval

Other Announcement

B N Rathi Securities Other Announcement

BN Rathi Securities Ltd has filed its quarterly shareholding pattern for the period ending September 30, 2026. This submission complies with SEBI Regulation 31 requirements.

Capital Structure Change

B N Rathi Securities Capital Structure Change

Darshan P Desai HUF and Priyanka Darshan Desai sold 5,45,163 and 4,75,991 shares of B.N. Rathi Securities, respectively, through open market transactions.

Annual General Meeting

B N Rathi Securities Annual General Meeting

B.N. Rathi Securities Ltd reported the conclusion of its 40th AGM. Shareholders approved financial statements, director appointments, and a dividend declaration.

Financial Results

B N Rathi Securities Q1 FY27 Results: Net Profit ₹2.5 Cr, Up 66.7% YoY

B N Rathi Securities Ltd reported revenue from operations of ₹16 Cr (+37.9% YoY) and net profit of ₹2.5 Cr (+66.7% YoY) for Q1 FY27.

Key figure

Net profit ₹2.5 Cr · +66.7% YoY

Board Meeting Date

B N Rathi Securities Board Meeting Date

B.N. Rathi Securities Ltd. will hold its 206th Board Meeting on August 12, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.

Board Meeting Outcome

B N Rathi Securities Board Meeting Outcome

B.N. Rathi Securities Ltd approved a ₹0.60 Crore investment as a Sponsor Contribution to an Alternative Investment Fund managed by its associate, B-Fly Asset Manager LLP.

Value

₹0.60 Cr

Regulatory ApprovalGrasim Industries Ltd GRASIMAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Grasim Industries Regulatory Approval

CCI approved subsidiary ABReN's acquisition of 100% of Solenergi Power from Shell Overseas. The approval clears a regulatory condition for the deal announced on 13 July 2026.

Regulatory ApprovalVedavaag Systems Ltd VEDAVAAG

Vedavaag Systems Regulatory Approval

Vedavaag's WOS received IRDAI Certificate of Registration to act as Direct Life & General Insurance Broker. The group enters regulated insurance broking activity.

Regulatory ApprovalHikal Ltd HIKALAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Hikal Regulatory Approval

Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.

Regulatory ApprovalSun Pharmaceutical Industries Ltd SUNPHARMAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Sun Pharmaceutical Industries Regulatory Approval

Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.

Regulatory ApprovalRNFI Services Ltd RNFIAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

RNFI Services Regulatory Approval

RNFI received RBI no-objection to acquire control of Smart Payment Solutions Private Limited. Remaining tranches may proceed, but no transaction value is disclosed.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.